Fig. 3From: Dipeptidyl peptidase 4 (DPP-4) inhibitors and cardiovascular outcomes in patients with type 2 diabetes mellitus (T2DM): a systematic review and meta-analysisCardiovascular outcomes observed with DPP-4 inhibitor users versus the control group (part 2)Back to article page